Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
Varelas, Xaralabos | Person |
Why?
|
A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma. | Academic Article |
Why?
|
A YAP/TAZ-Regulated Transcriptional Signature Associated with Oral Squamous Cell Carcinoma | Academic Article |
Why?
|
Glutamine-utilizing transaminases are a metabolic vulnerability of TAZ/YAP-activated cancer cells. | Academic Article |
Why?
|
YAP/TAZ-NRG1 crosstalk in airway epithelial cell fate control | Grant |
Why?
|
Yap/Taz inhibit goblet cell fate to maintain lung epithelial homeostasis. | Academic Article |
Why?
|
A Computational Model of YAP/TAZ Mechanosensing. | Academic Article |
Why?
|
Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression. | Academic Article |
Why?
|
CRISPR-Mediated Approaches to Regulate YAP/TAZ Levels. | Academic Article |
Why?
|
Hippo-Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior. | Academic Article |
Why?
|
Integrin-FAK-CDC42-PP1A signaling gnaws at YAP/TAZ activity to control incisor stem cells. | Academic Article |
Why?
|
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis. | Academic Article |
Why?
|
TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation. | Academic Article |
Why?
|
The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7. | Academic Article |
Why?
|
Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis. | Academic Article |
Why?
|